QuickView for Thy-1;jsessionid=011CF923678866240A0AFA39DB3FF7BC;jsessionid=3742F3AB11896D86E6235173F818F4D1;jsessionid=DA88A339DE20AE879BF1AB79CF1977C3;jsessionid=00BF7F9D11F35750F011682B68A4C318;jsessionid=1C90E1941BDB42F0F63465EA7A57B214;jsessionid=C24FE51FBF02ABDF1AF9768E463AED6F (gene)

1. Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblas…
2. Donor CD7 Chimeric Antigen Receptor T Cell Bridging to Allogeneic Hematopoietic Stem Cell Transplant…
3. Expression of CD7 and its correlation with prognosis in patients with NK/T-cell lymphoma].
4. Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed a…
5. An antibody-drug conjugate with intracellular drug release properties showing specific cytotoxicity …

There were no clinical trials for Thy-1;jsessionid=011CF923678866240A0AFA39DB3FF7BC;jsessionid=3742F3AB11896D86E6235173F818F4D1;jsessionid=DA88A339DE20AE879BF1AB79CF1977C3;jsessionid=00BF7F9D11F35750F011682B68A4C318;jsessionid=1C90E1941BDB42F0F63465EA7A57B214;jsessionid=C24FE51FBF02ABDF1AF9768E463AED6F